| ||||||||||||||||||||||||||||
|
Oltean et al. 10.1073/pnas.0603090103. |
Supporting Figure 6
Supporting Table 1
Supporting Figure 7
Supporting Figure 8
Fig. 6. Fluorescence cytometry analysis of pRint and pRIIIcI2 stably transfected DT3 cells (left two images) and AT3 cells (right two images). M1 represents a marker indicating fluorescence positive readings (i.e., above the background fluorescence for untransfected cells). The expression of red fluorescent protein (RFP) is relatively homogeneous, although it is clear that a small fraction of the Rint cells may have lost the reporter.
Fig. 7. Mesenchymal-epithelial transitions (MET) in tumors. (A) Zonula occludens protein-1 (ZO-1) counterstaining is consistent with MET. Example of a section from RIIIcI2 tumors shows that the red fluorescent cells also stained positive for ZO-1. Images were acquired at ´200 magnification. (B) Vimentin counterstaining. Example of a section from RIIIcI2 tumors shows that the red fluorescent cells have no or have low vimentin expression. The RFP+ cells are within a larger tumor region that has low vimentin staining. Images were acquired at ´200 magnification.
Fig. 8. A metastatic nodule does not express RFP, whereas in the lung tissue around it there are RFP-expressing metastatic cells. (A) Phase-contrast and hematoxylin/eosin staining of a large metastatic nodule in the lung of an animal bearing an AT3-RIIIcI2 tumor (´40 magnification). (B) (Upper) Fluorescence pictures of lung tissue in the vicinity of the nodule, middle of the nodule, and at the interface of the nodule with the lung tissue. (Lower) Phase-contrast images of the same fields. Images were acquired at ´400 magnification.
Table 1. RFP+ clusters in tumors and in metastases in lungs: Frequency and characterization
|
Tumors (animals) |
Frequency of tumor sections with at least one RFP+ cluster* |
Frequency of RFP+ clusters that express E-cadherin† |
Frequency of RFP+ clusters that are present in stromal regions‡ |
RFP+ cells in lungs |
Frequency of RFP+ metastasis that express E-cadherin§ |
|
AT3-RIIIcI2 tumors (males) |
|||||
|
01 |
1/6 |
0/1 |
ND |
N |
NA |
|
02 |
4/8 |
4/4 |
4/4 |
Y |
1/2 |
|
03 |
3/7 |
0/2 |
0/2 |
Y |
2/2 |
|
04 |
4/7 |
2/2 |
2/2 |
Y |
2/2 |
|
05 |
2/5 |
1/1 |
ND |
Y |
0/2 |
|
06 |
1/5 |
1/1 |
ND |
ND |
NA |
|
07 |
1/3 |
1/1 |
ND |
Y |
2/2 |
|
08 |
3/6 |
2/3 |
2/2 |
Y |
1/1 |
|
09 |
0/8 |
NA5 |
ND |
Y |
2/2 |
|
Male totals |
19/55 |
11/15 |
8/10 |
NA |
10/13 |
|
AT3-RIIIcI2 tumors (females) |
|||||
|
01 |
1/8 |
1/1 |
ND |
Y |
ND |
|
02 |
0/8 |
NA |
ND |
Y |
2/2 |
|
03 |
3/3 |
ND |
ND |
Y |
1/1 |
|
04 |
5/8 |
1/1 |
4/4 |
Y |
2/2 |
|
05 |
2/6 |
1/1 |
2/2 |
Y |
0/2 |
|
Female totals |
11/33 |
3/3 |
6/6 |
NA |
5/7 |
|
Total AT3-RIIIcI2 tumors |
30/88 |
14/18 |
14/16 |
NA |
15/20 |
|
AT3-RD,D tumors (males) |
|||||
|
01 |
0/4 |
NA |
NA |
NA |
NA |
|
02 |
0/4 |
NA |
NA |
NA |
NA |
|
03 |
0/4 |
NA |
NA |
NA |
NA |
|
04 |
0/4 |
NA |
NA |
NA |
NA |
|
Total R∆,∆ tumors |
0/16 |
NA |
NA |
NA |
NA |
*Frequency = No. of sections with at least one RFP+ island/no. of sections examined. Note that 12 of 14 tumors had at least one RFP+ cluster.
†
Analysis of tumor sections with one RFP+ island that were costained with E-cadherin (see Fig. 3).‡
Stromal regions were identified by using Masson’s Trichrome stain (see Fig. 4).§
Analysis of lung sections with one RFP+ island that were costained with E-cadherin (see Fig. 5).¶
NA, not applicable; ND, not determined.
| ||||||||||||||||||||||||||||